West Pharmaceutical Services Long Term Debt 2010-2023 | WST

West Pharmaceutical Services long term debt from 2010 to 2023. Long term debt can be defined as the sum of all long term debt fields.
  • West Pharmaceutical Services long term debt for the quarter ending December 31, 2023 was $0.073B, a 64.78% decline year-over-year.
  • West Pharmaceutical Services long term debt for 2023 was $0.073B, a 64.78% decline from 2022.
  • West Pharmaceutical Services long term debt for 2022 was $0.207B, a 1.01% decline from 2021.
  • West Pharmaceutical Services long term debt for 2021 was $0.209B, a 17.44% decline from 2020.
West Pharmaceutical Services Annual Long Term Debt
(Millions of US $)
2023 $73
2022 $207
2021 $209
2020 $253
2019 $255
2018 $196
2017 $197
2016 $226
2015 $229
2014 $308
2013 $371
2012 $379
2011 $299
2010 $358
2009 $379
West Pharmaceutical Services Quarterly Long Term Debt
(Millions of US $)
2023-12-31 $73
2023-09-30 $152
2023-06-30 $206
2023-03-31 $206
2022-12-31 $207
2022-09-30 $207
2022-06-30 $208
2022-03-31 $208
2021-12-31 $209
2021-09-30 $210
2021-06-30 $252
2021-03-31 $252
2020-12-31 $253
2020-09-30 $253
2020-06-30 $254
2020-03-31 $254
2019-12-31 $255
2019-09-30 $195
2019-06-30 $196
2019-03-31 $196
2018-12-31 $196
2018-09-30 $196
2018-06-30 $196
2018-03-31 $198
2017-12-31 $197
2017-09-30 $197
2017-06-30 $196
2017-03-31 $194
2016-12-31 $226
2016-09-30 $229
2016-06-30 $229
2016-03-31 $230
2015-12-31 $229
2015-09-30 $232
2015-06-30 $232
2015-03-31 $232
2014-12-31 $308
2014-09-30 $316
2014-06-30 $359
2014-03-31 $391
2013-12-31 $371
2013-09-30 $381
2013-06-30 $395
2013-03-31 $428
2012-12-31 $379
2012-09-30 $362
2012-06-30 $296
2012-03-31 $295
2011-12-31 $299
2011-09-30 $323
2011-06-30 $367
2011-03-31 $365
2010-12-31 $358
2010-09-30 $369
2010-06-30 $357
2010-03-31 $348
2009-12-31 $379
2009-09-30 $393
2009-06-30 $386
2009-03-31 $384
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $28.565B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $69.909B 18.71
Becton Dickinson (BDX) United States $67.707B 19.66
Cardinal Health (CAH) United States $25.143B 15.11
Align Technology (ALGN) United States $23.470B 47.33
Cooper (COO) United States $18.222B 27.57
Labcorp (LH) United States $17.496B 14.94
Henry Schein (HSIC) United States $9.348B 16.17
DENTSPLY SIRONA (XRAY) United States $6.399B 16.86
Merit Medical Systems (MMSI) United States $4.307B 24.65
STAAR Surgical (STAA) United States $2.355B 74.14
Patterson (PDCO) United States $2.327B 11.15
CONMED (CNMD) United States $2.196B 20.67
Atrion (ATRI) United States $0.713B 36.74
Lifevantage (LFVN) United States $0.082B 13.34
Pro-Dex (PDEX) United States $0.066B 25.00
Biolase (BIOL) United States $0.005B 0.00